Target intelligence / Profile preview

DNA polymerase alpha and related replicative DNA polymerases (Pol alpha/delta/epsilon)

Target
Pol alpha/delta/epsilon
Molecular classification
Enzyme, DNA-directed DNA polymerase, Family B DNA polymerase
01

Overview

DNA polymerase alpha, delta, and epsilon are the essential enzymes responsible for the replication of the eukaryotic nuclear genome (UniProt P09884, P28340, Q9Y5S4). DNA polymerase alpha, in complex with primase, initiates DNA synthesis by creating short RNA-DNA primers, which are then extended by DNA polymerase epsilon on the leading strand and DNA polymerase delta on the lagging strand (Wikipedia: DNA polymerase). These enzymes are members of the Family B DNA polymerases and are characterized by high fidelity and processivity, often requiring the sliding clamp PCNA for efficient synthesis (NIH: PMC2519115). Beyond their roles in replication, they are integral to various DNA repair pathways, such as nucleotide excision repair and base excision repair (PubMed: 22119860). Due to their essential role in cell proliferation, they are significant therapeutic targets in oncology and virology; for instance, nucleoside analogs like cytarabine and gemcitabine target these polymerases to inhibit cancer cell growth (NIH: PMC2519115). Mutations in the proofreading domains of POLE and POLD1 are linked to hypermutated tumor phenotypes, which serve as important biomarkers for predicting response to immune checkpoint inhibitors (PubMed: 24022480).

Other names
Replicative DNA polymerasesFamily B DNA polymerasesDNA polymerase alpha-primase complexDNA polymerase delta complexDNA polymerase epsilon complexNuclear replicative polymerases
02

Mechanism of action

Inhibition of DNA synthesis through competitive binding with deoxyribonucleotide triphosphates (dNTPs), incorporation into the nascent DNA strand causing chain termination, or direct allosteric/active-site inhibition of the catalytic subunits.

03

Biological functions

DNA replication initiationLeading strand DNA synthesisLagging strand DNA synthesisDNA repairCell cycle progressionGenome maintenance
04

Disease associations

CancerViral infectionAutoimmune diseaseImmunodeficiency
05

Safety considerations

MyelosuppressionGastrointestinal toxicityGenotoxicity and potential for secondary malignanciesAcquired drug resistance via polymerase mutations
06

Interacting drugs

Aphidicolin

7 more in the full profile.

07

Biomarkers

POLE mutation statusPOLD1 mutation statusMicrosatellite instability (MSI)Tumor mutational burden (TMB)PCNA expression levelsγH2AX (DNA damage marker)

Beyond the preview

Go deeper on DNA polymerase alpha and related replicative DNA polymerases (Pol alpha/delta/epsilon).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase alpha and related replicative DNA polymerases (Pol alpha/delta/epsilon).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call